Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ARKG vs. HELX: which is better?

Bottom line

ARKG vs HELX: the short answer

ARKG (ARK Genomic Revolution ETF) and HELX (Franklin Genomic Advancements ETF) are quite different portfolios: only about 26% of their top holdings (by weight) are shared.

HELX is cheaper at 0.5% vs 0.75% — a difference of $25 a year per $10,000 invested.

Over five years, HELX returned −3.8% a year vs −6.5% for ARKG (reporting dates differ).

Updated Nov 19, 2026

ARKG vs HELX side by side

ARKGHELX
TypeETFETF
Fund familyARK InvestFranklin Templeton
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.75%0.5%
Annual cost per $10k$75$50
10-yr cost on $10k (prospectus)$930$629
Max front loadNoneNone
12b-1 fee0%0%
1-yr return−28.1%+25.9%
5-yr return (annualized)−6.5%−3.8%
10-yr return (annualized)+1.9%—
Best quarter+66.0%+19.6%
Worst quarter−31.5%−23.7%
Net assets (fund)$1.6B$27.9M
Number of holdings3363
Portfolio turnover33%29%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearARKGHELXDifference
2024−28.1%−5.1%−23.0%
2023+16.2%+1.2%+15.0%
2022−53.9%−37.9%−16.1%
2021−33.9%+9.7%−43.6%

Source: Fund prospectus bar charts

Holdings overlap

8 of ARKG's top 25 holdings also appear in HELX's top 25.

Shared top holdings
HoldingARKGHELX
Twist Bioscience Corp7.73%2.85%
Tempus Ai Inc6.56%1.95%
Guardant Health Inc4.74%9.09%
Eli Lilly & Company4.68%2.95%
Natera Inc4.13%7.46%
Adaptive Biotechnologies Corp2.57%3.99%
Veracyte Inc2.55%1.64%
Ionis Pharmaceuticals Inc1.77%1.91%

Source: SEC Form N-PORT

ARKG top 10

  1. 10x Genomics Inc — 9.39%
  2. Twist Bioscience Corp — 7.73%
  3. Tempus Ai Inc — 6.56%
  4. Crispr Therapeutics Ag — 6.29%
  5. Personalis Inc — 5.47%
  6. Absci Corp — 5.14%
  7. Guardant Health Inc — 4.74%
  8. Illumina Inc — 4.74%
  9. Eli Lilly & Company — 4.68%
  10. Caredx Inc — 4.30%

HELX top 10

  1. Guardant Health Inc — 9.09%
  2. Natera Inc — 7.46%
  3. Krystal Biotech Inc — 6.33%
  4. Ligand Pharmaceuticals Inc — 4.62%
  5. Adaptive Biotechnologies Corp — 3.99%
  6. United Therapeutics Corp — 3.51%
  7. Bridgebio Pharma Inc — 3.50%
  8. Eli Lilly & Company — 2.95%
  9. Twist Bioscience Corp — 2.85%
  10. Vertex Pharmaceuticals Inc — 2.75%

FAQ

What is the difference between ARKG and HELX?
ARKG (ARK Genomic Revolution ETF) and HELX (Franklin Genomic Advancements ETF) are quite different portfolios: only about 26% of their top holdings (by weight) are shared. HELX is cheaper at 0.5% vs 0.75% — a difference of $25 a year per $10,000 invested.
Which is cheaper, ARKG or HELX?
HELX has the lower expense ratio (0.5%).
Should I own both ARKG and HELX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.